-
Aloha Health Network posted an update in the group Bile Duct Cancer – Extrahepatic Advocate Network
For advanced biliary tract cancer patients that also have reduced kidney function (as measured by Creatinine Clearance (CCr) between 50-80ml/min), this study presented January 18, 2019 showed that gemcitabine (GEM) plus S-1 (GS) was better in terms of overall survival, progression free survival, and blood counts than the typical standard of care for 1st line treatment, which is GEM plus cisplatin (GC). Accordingly, ASCO is considering gemcitabine (GEM) plus S-1 (GS) might be recommended for the population with lower renal function in the treatment for advanced biliary tract cancer.
Meeting Library | Meeting Library2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300
Recent Activity In Bile Duct Cancer – Extrahepatic Advocate Network
Visit The CommunityJoin The Discussion-
-
Aloha Health Network posted an update in the group Bile Duct Cancer – Extrahepatic Advocate Network
For advanced biliary tract cancer patients that also have reduced kidney function (as measured by Creatinine Clearance (CCr) between 50-80ml/min), this study presented January 18, 2019 showed that gemcitabine (GEM) plus S-1 (GS) was better in terms of overall survival, progression free survival, and blood counts than the typical standard of care for 1st line treatment, which is GEM plus cisplatin (GC). Accordingly, ASCO is considering gemcitabine (GEM) plus S-1 (GS) might be recommended for the population with lower renal function in the treatment for advanced biliary tract cancer.
Meeting Library | Meeting Library2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 -
Aloha Health Network joined the group Bile Duct Cancer – Extrahepatic Advocate Network
-
Ericdrew18 joined the group Bile Duct Cancer – Extrahepatic Advocate Network
-
Eric Drew joined the group Bile Duct Cancer – Extrahepatic Advocate Network
-
WeHeal created the group Bile Duct Cancer – Extrahepatic Advocate Network
